Development of vasopressor specific vasotocin analogues with prolonged effects-Reference-Cited by-同舟云学术

Development of vasopressor specific vasotocin analogues with prolonged effects

Published:1991 Issue: Volume: Page:671-673
ISSN:
Container-title:Peptides 1990
language:
Short-container-title:

Author:

Aurell Carl-Johan,Bengtsson Bengt,Ekholm Kjell,Kasprzykowska Regina,Nilsson Anders,Persson Roger,Trojnar Jerzy,Abbe Maria,Melin Per

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-94-011-3034-9_278

Reference3 articles.

1. Aurell, C.-J., Bengtsson, B., Kasprzykowski, F., Lawitz, K., Melin, P. and Trojnar, J., In Rivier, J.E. and Marshall, G.R. (Eds.) Peptides: Chemistry, Structure and Biology (Proceedings of the 11th American Peptide Symposium), ESCOM, Leiden, 1990, pp. 293–296.

2. Jost, K., In Jost, K., Lebl, M. and Brtnik, F. (Eds.) Handbook of Neurohypophyseal Hormone Analogues, Vol. II, Part I, CRC Press, Boca Raton, FL, 1987, p. 1.

3. Kyncl, J., Rezabek, K., Kasafirek, E., Pliska, V. and Rudinger, J., Eur. Pharmacol., 28(1974)294.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological characterization of FE 201874, the first selective high affinity rat V1Avasopressin receptor agonist;British Journal of Pharmacology;2013-08-27

2. Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics;Journal of Neuroendocrinology;2012-03-26

3. New, Potent, Selective, and Short-Acting Peptidic V1a Receptor Agonists;Journal of Medicinal Chemistry;2011-06-20

4. Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1aReceptor Full Agonist for the Treatment of Vasodilatory Hypotension;Journal of Pharmacology and Experimental Therapeutics;2011-03-16